Godavari Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider and approve unaudited standalone financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs Ltd has informed BSE that its Board of Directors will meet on 13th August 2025 to consider and approve the unaudited standalone financial results for Q1 ended 30th June 2025. The company has also rescheduled its 37th Annual General Meeting, which was originally set for 28th August 2025; the new date, time, and venue will be communicated later. The trading window for designated persons and their immediate relatives remains closed from 1st July 2025 and will reopen on 16th August 2025, covering the results announcement period.
This is a routine regulatory filing with no immediate impact on shareholders. Investors should watch the Q1 results announcement on or after 13th August for actual performance data. The AGM rescheduling is procedural and the new date is yet to be announced.